Company news

Polynovo Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Final Director's Interest Notice - Dr Elliott

November 2, 2026

Final Director's Interest Notice - Ms Emmanuel-Donnelly

November 2, 2026

Results of Meeting

October 29, 2026

PolyNovo - FY26 Annual General Meeting

October 29, 2026

Change in substantial holding

October 27, 2026

CFO Jan Gielen to Depart PolyNovo

October 19, 2026

PolyNovo Notice of Annual General Meeting

September 27, 2026

Dean Phizacklea and Andrew Price Appointed to PNV Board

September 16, 2026

PolyNovo FY26 Corporate Governance Statement

September 14, 2026

PolyNovo FY26 Appendix 4G

September 14, 2026

PolyNovo FY26 Annual Report

September 14, 2026

PolyNovo FY26 Results Presentation Webinar Recording

August 26, 2026

FY26 Full Year Results and Appendix 4E

August 25, 2026

FY26 Full Year Results Investor Presentation

August 25, 2026

ASX Announcement - FY26 Full Year Results

August 25, 2026

Ceasing to be a substantial holder

August 23, 2026

PolyNovo FY26 Results Presentation - Registration Details

August 16, 2026

Becoming a substantial holder

July 27, 2026

PolyNovo FY26 Trading Update

July 22, 2026

Response to ASX Price Query

May 14, 2026

Appendix 4D & H1 FY26 Financial Statements

February 20, 2026

1H FY26 Results Presentation

February 20, 2026

1H26 Trading Result (unaudited)

January 18, 2026

Trading Results Q1 FY26 (unaudited)

October 19, 2025

CEO appointment - Mr. Bruce Peatey

October 16, 2025

Chronic diabetic-related wound study results

September 12, 2025

Trading Halt

September 12, 2025

Pause in Trading

September 12, 2025

S&P DJI Announces September 2025 Quarterly Rebalance

September 5, 2025

U.S. Medicare Reimbursement Proposal

September 2, 2025

FY25 Results Presentation

August 25, 2025

Appendix 4E and FY25 Financial Statements

August 25, 2025

FY25 Trading Result (unaudited)

July 29, 2025

BTM delivers positive First in Man results in Cell Therapies

May 13, 2025

First A$11m sales month

April 9, 2025

Change of CEO

March 10, 2025

Additional response to articles in 'Margin Call'

March 7, 2025

Response to article in 'Margin Call'

March 6, 2025

1H FY25 Results Presentation

February 24, 2025

Appendix 4D & 1H FY25 Report

February 24, 2025

1H FY25 Trading Result (unaudited)

January 17, 2025

First $A10m sales month

December 22, 2024

Appendix 4E and FY24 Financial Statements

August 23, 2024

FY24 Trading Result (unaudited)

July 23, 2024

First $A9M sales month and $A10M revenue month

May 7, 2024

India update

March 3, 2024

1H FY24 Results Presentation

February 27, 2024

Appendix 4D & 1H FY24 Report

February 27, 2024

1H24 Trading Result (unaudited)

January 22, 2024

First $A8M sales month and $A9M revenue month

December 6, 2023

Older news releases →

Calls

Decks

The 5 newest of 36 decks. Every deck is listed under its year.